Prelude PRLD 深 滬
交易中 09-10 11:13:49 美东时间
1.21
+0.020
+1.68%
華盛通- 最 高1.25
- 今 開1.20
- 成交量 6.01万股
- 最 低 1.1801
- 昨 收 1.19
- 總市值 6831.72万
- 52周最高 2.56
- 市盈率 靜 --
- 換手率 0.11%
- 52周最低 0.6101
- 委 比 -12.28%
- 總股本 5646.05万
- 歷史最高 95.375
- 量 比 1.86
- 振 幅 5.87%
- 歷史最低 0.6101
- 每 手 1
- 風險率 0.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Prelude Therapeutics shares are trading lower. The company reported Q2 financial results.
Prelude Therapeutics shares are trading lower. The company reported Q2 financia...
08-16 00:01
Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Prelude Therapeutics reported Q2 2025 financial results with $77.3M in cash, funding operations into Q2 2026. R&D expenses decreased to $25.8M, G&A to $6.4M, with net loss of $31.2M. Company advanced PRT7732 (oral SMARCA2 degrader) to 7th dose cohort and paused PRT3789 IV program. KAT6A degrader IND on track for H1 2026. Preclinical data highlighted precision ADCs and mCALR-targeted therapies.
08-14 11:00
Deal Dispatch: Performance Food Group And Claire's Lead A Week Of Big Auctions, Retail Woes
Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire's files bankruptcy amid retail struggles.
08-09 04:02
单月超20亿美元，Biotech行业融资规模重返疫情前水平
转自：新康界 今年5月，美国及欧洲的生物医药行业共发生23起融资事件，融资规模达20.2亿美元（约143.03亿人民币），环比增幅达59.18%，其中值得关注的...
06-30 17:32
12款小分子新药化学结构首次公开
转自：中国医药报 在前不久美国化学会（ACS）举行的2025春季会议上，12款已进入或即将进入临床试验的小分子药物的化学结构首次公开亮相，这些潜在的新药适应证...
06-19 08:18
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
Prelude Therapeutics will participate in two healthcare conferences in June 2025. Kris Vaddi, CEO, will join fireside chats at the Jefferies Global Healthcare Conference on June 5 and the Goldman Sachs Annual Global Healthcare Conference on June 11. Live webcasts and recordings will be available on the company’s website for 90 days. Prelude is a precision oncology company developing innovative cancer treatments, including novel degraders and ADCs...
06-02 11:30
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 10.9% to $0.67 durin...
05-28 05:06
The Wyatt Foundation and The Conceive Fertility Foundation Announce Launch of 2025 IVF Grant Program
Launching during RESOLVE's National Infertility Awareness Week® 2025, the program will award $15,000 grants to five patients who need fertility care to build their families; New program part...
04-21 22:40
美股大行评级 | 潜在涨幅147.43%！HC Wainwright & Co.上调Pacira BioSciences目标价至65美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1116650478822592513.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Pacira BioSciences(PCRX)"买入"评级，目标价从48美元升至65美元</p> <p>• 瑞穗：上调Amylyx Pharmaceuticals(AM
04-09 08:50
